Drug patent expiries ranked by the Medicare Part D spending exposed to them
Call this server's tools from your browser. Nothing to install.
Requests go through mcptry because browsers can't call most MCP servers directly. Header values are sent to the server for that request only and are never stored or logged.
Tool list from our last check. Connect live to refresh it.
Rank upcoming FDA Orange Book patent and exclusivity expiries BY the gross Medicare Part D spending exposed to them, with marketed-generic status for each ranked drug resolved from live CMS NADAC price evidence. Answers which expiries matter, not merely which come first. Reports EXPOSURE, never forecast savings. Spending is gross of manufacturer rebates. Orange Book small molecules only, so biologics — among the largest Part D line items — are excluded, and the headline total must not be read as spending that will "go generic".
How many drugs to rank, default 25
Months ahead to include, default 24
This tool isn't marked read-only, so it may change something on the server or in an account you connected.
Rank upcoming FDA Orange Book patent and exclusivity expiries BY the gross Medicare Part D spending exposed to them, with marketed-generic status for each ranked drug resolved from live CMS NADAC price evidence. Answers which expiries matter, not merely which come first. Reports EXPOSURE, never forecast savings. Spending is gross of manufacturer rebates. Orange Book small molecules only, so biologics — among the largest Part D line items — are excluded, and the headline total must not be read as spending that will "go generic".
| Argument | Type | Description |
|---|---|---|
| limit | string |
| How many drugs to rank, default 25 |
| window | string | Months ahead to include, default 24 |
{
"type": "object",
"required": [],
"properties": {
"limit": {
"type": "string",
"description": "How many drugs to rank, default 25"
},
"window": {
"type": "string",
"description": "Months ahead to include, default 24"
}
}
}